These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29262333)

  • 1. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia.
    An D; Schneller JL; Frassetto A; Liang S; Zhu X; Park JS; Theisen M; Hong SJ; Zhou J; Rajendran R; Levy B; Howell R; Besin G; Presnyak V; Sabnis S; Murphy-Benenato KE; Kumarasinghe ES; Salerno T; Mihai C; Lukacs CM; Chandler RJ; Guey LT; Venditti CP; Martini PGV
    Cell Rep; 2017 Dec; 21(12):3548-3558. PubMed ID: 29262333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia.
    An D; Frassetto A; Jacquinet E; Eybye M; Milano J; DeAntonis C; Nguyen V; Laureano R; Milton J; Sabnis S; Lukacs CM; Guey LT
    EBioMedicine; 2019 Jul; 45():519-528. PubMed ID: 31303505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved therapeutic efficacy in two mouse models of methylmalonic acidemia (MMA) using a second-generation mRNA therapy.
    Coughlan KA; Eybye M; Henderson N; DeAntonis CM; Frassetto A; Hanahoe E; Ketova T; Jacquinet E; Presnyak V; Jain R; Marshall J; Martini PGV
    Mol Genet Metab; 2024; 143(1-2):108560. PubMed ID: 39121792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for Methylmalonic Acidemia: Past, Present, and Future.
    Chandler RJ; Venditti CP
    Hum Gene Ther; 2019 Oct; 30(10):1236-1244. PubMed ID: 31303064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia.
    Chandler RJ; Venturoni LE; Liao J; Hubbard BT; Schneller JL; Hoffmann V; Gordo S; Zang S; Ko CW; Chau N; Chiang K; Kay MA; Barzel A; Venditti CP
    Hepatology; 2021 Jun; 73(6):2223-2237. PubMed ID: 32976669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
    Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
    Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA).
    Chandler RJ; Venditti CP
    Mol Genet Metab; 2012 Nov; 107(3):617-9. PubMed ID: 23046887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing.
    Venturoni LE; Chandler RJ; Liao J; Hoffmann V; Ramesh N; Gordo S; Chau N; Venditti CP
    Mol Genet Metab; 2022; 137(1-2):1-8. PubMed ID: 35868241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.
    Chandler RJ; Sloan J; Fu H; Tsai M; Stabler S; Allen R; Kaestner KH; Kazazian HH; Venditti CP
    BMC Med Genet; 2007 Oct; 8():64. PubMed ID: 17937813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.
    Chandler RJ; Venditti CP
    Mol Ther; 2010 Jan; 18(1):11-6. PubMed ID: 19861951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of methylmalonic aciduria in vivo using a codon-optimized lentiviral vector.
    Wong ES; McIntyre C; Peters HL; Ranieri E; Anson DS; Fletcher JM
    Hum Gene Ther; 2014 Jun; 25(6):529-38. PubMed ID: 24568291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.
    Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP
    Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAT-MTS-MCM fusion proteins reduce MMA levels and improve mitochondrial activity and liver function in MCM-deficient cells.
    Erlich-Hadad T; Hadad R; Feldman A; Greif H; Lictenstein M; Lorberboum-Galski H
    J Cell Mol Med; 2018 Mar; 22(3):1601-1613. PubMed ID: 29265583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes.
    Chandler RJ; Tsai MS; Dorko K; Sloan J; Korson M; Freeman R; Strom S; Venditti CP
    BMC Med Genet; 2007 Apr; 8():24. PubMed ID: 17470278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the pathophysiology of methylmalonic acidemia.
    Head PE; Meier JL; Venditti CP
    J Inherit Metab Dis; 2023 May; 46(3):436-449. PubMed ID: 37078237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin.
    Head PE; Myung S; Chen Y; Schneller JL; Wang C; Duncan N; Hoffman P; Chang D; Gebremariam A; Gucek M; Manoli I; Venditti CP
    Sci Transl Med; 2022 May; 14(646):eabn4772. PubMed ID: 35613279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency.
    Almási T; Guey LT; Lukacs C; Csetneki K; Vokó Z; Zelei T
    Orphanet J Rare Dis; 2019 Apr; 14(1):84. PubMed ID: 31023387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.
    Manoli I; Sysol JR; Epping MW; Li L; Wang C; Sloan JL; Pass A; Gagné J; Ktena YP; Li L; Trivedi NS; Ouattara B; Zerfas PM; Hoffmann V; Abu-Asab M; Tsokos MG; Kleiner DE; Garone C; Cusmano-Ozog K; Enns GM; Vernon HJ; Andersson HC; Grunewald S; Elkahloun AG; Girard CL; Schnermann J; DiMauro S; Andres-Mateos E; Vandenberghe LH; Chandler RJ; Venditti CP
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
    Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
    Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
    Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
    Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.